Irina Shchaveleva

1.4k total citations
10 papers, 1.1k citations indexed

About

Irina Shchaveleva is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Irina Shchaveleva has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Molecular Biology. Recurrent topics in Irina Shchaveleva's work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). Irina Shchaveleva is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). Irina Shchaveleva collaborates with scholars based in United States and Japan. Irina Shchaveleva's co-authors include Gary D. Kruh, Martin G. Belinsky, Zhe‐Sheng Chen, Elizabeth Hopper-Borge, Hao Zeng, Douglas D. Ross, Robert W. Robey, Susan E. Bates, Elena Kotova and Yoshikazu Sugimoto and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Irina Shchaveleva

10 papers receiving 1.1k citations

Peers

Irina Shchaveleva
D D Ross United States
G L Scheffer Netherlands
Elaine Paul United States
C.M. Kuiper Netherlands
N A Brophy United States
Ietje Kathmann Netherlands
C.K. van Kalken Netherlands
Irina Shchaveleva
Citations per year, relative to Irina Shchaveleva Irina Shchaveleva (= 1×) peers Elizabeth Hopper-Borge

Countries citing papers authored by Irina Shchaveleva

Since Specialization
Citations

This map shows the geographic impact of Irina Shchaveleva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irina Shchaveleva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irina Shchaveleva more than expected).

Fields of papers citing papers by Irina Shchaveleva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irina Shchaveleva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irina Shchaveleva. The network helps show where Irina Shchaveleva may publish in the future.

Co-authorship network of co-authors of Irina Shchaveleva

This figure shows the co-authorship network connecting the top 25 collaborators of Irina Shchaveleva. A scholar is included among the top collaborators of Irina Shchaveleva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irina Shchaveleva. Irina Shchaveleva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Shaller, Calvin, Mohan Doss, Irina Shchaveleva, et al.. (2010). Evaluation of the Anti-HER2 C6.5 Diabody as a PET Radiotracer to Monitor HER2 status and Predict Response to Trastuzumab Treatment. Clinical Cancer Research. 17(6). 1509–1520. 29 indexed citations
3.
Robinson, Matthew K., Eva Horak, Calvin Shaller, et al.. (2008). Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro. British Journal of Cancer. 99(9). 1415–1425. 102 indexed citations
4.
Belinsky, Martin G., Ping Guo, Kun Hee Lee, et al.. (2007). Multidrug Resistance Protein 4 Protects Bone Marrow, Thymus, Spleen, and Intestine from Nucleotide Analogue–Induced Damage. Cancer Research. 67(1). 262–268. 63 indexed citations
5.
Belinsky, Martin G., Paul A. Dawson, Irina Shchaveleva, et al.. (2005). Analysis of the In Vivo Functions of Mrp3. Molecular Pharmacology. 68(1). 160–168. 129 indexed citations
6.
Belinsky, Martin G., Irina Shchaveleva, Zhe‐Sheng Chen, Alan C. Sartorelli, & Gary D. Kruh. (2004). Analysis of the contribution of MRP3 to in vivo chemosensitivity using knock out mice.. Cancer Research. 64. 568–568. 1 indexed citations
7.
Hopper-Borge, Elizabeth, Zhe‐Sheng Chen, Irina Shchaveleva, Martin G. Belinsky, & Gary D. Kruh. (2004). Analysis of the Drug Resistance Profile of Multidrug Resistance Protein 7 (ABCC10). Cancer Research. 64(14). 4927–4930. 151 indexed citations
8.
Chen, Zhe‐Sheng, Elizabeth Hopper-Borge, Martin G. Belinsky, et al.. (2003). Characterization of the Transport Properties of Human Multidrug Resistance Protein 7 (MRP7, ABCC10). Molecular Pharmacology. 63(2). 351–358. 142 indexed citations
9.
Chen, Zhe‐Sheng, Robert W. Robey, Martin G. Belinsky, et al.. (2003). Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.. PubMed. 63(14). 4048–54. 258 indexed citations
10.
Belinsky, Martin G., Zhe‐Sheng Chen, Irina Shchaveleva, Hao Zeng, & Gary D. Kruh. (2002). Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).. PubMed. 62(21). 6172–7. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026